The ReSound OMNIA miniRIE is a premium prescription hearing aid priced at $4,764, earning an A grade with a SoundScore of 4.02/5 in HearAdvisor's lab testing. As a 2022 release, it has received Expert's Choice Awards in both 2023 and 2024, though its performance profile shows meaningful strengths and weaknesses worth considering.
In our testing, the OMNIA miniRIE excelled at speech in quiet, scoring 0.89 points above the category average—a notable strength for users who prioritize conversation clarity in calm environments. Own-voice comfort also measured slightly above average, suggesting the closed dome coupling provides reasonable occlusion management. However, the device showed limitations in more challenging conditions: speech in noise performance fell 0.52 points below average, and music streaming quality trailed by 0.53 points.
At this price point, the OMNIA miniRIE faces stiff competition. Premium alternatives like the Oticon Intent (4.70/5) and Phonak Sphere Infinio (4.64/5) deliver stronger overall performance at similar prices. Budget-conscious consumers may also note that the Sony CRE-C10, an OTC option at $798, achieved a comparable SoundScore of 4.07/5 in our testing.
The ReSound OMNIA miniRIE is best suited for users who prioritize speech clarity in quieter settings and value the rechargeable design with both iPhone and Android streaming capability. Those frequently in noisy environments or who stream music regularly may want to compare alternatives before committing to this premium price tier.
